Baymatob™ awarded $2.96M

News Hits: 2794

BaymatobTM has been awarded $2.96M by the NSW Medical Devices Fund to conduct pre-trial development on OliTM.  A total of four companies received funding for the 2019 round of the Medical Devices Fund with around $6.8M being awarded. BaymatobTM is a recipient of the NSW Medical Devices Fund, having received $1.47M in 2017 towards the development of OliTM. The NSW Medical Devices Fund began in 2013 and has awarded more than $50 million across 31 different technologies. This is a unique fund making it possible to progress the development and commercialisation of medical technologies within Australia.

Further information on the fund and recipients can be found here. 

Baymatob™ team at the NSW Medical Device Fund announcements  from left, Saba Easwaramoorthy, Karin Birkner, Dr Sarah McDonald, Laura Mullins, Nicole Vu, and Dr Rishi Ramakrishnan (source: BaymatobTM)
Baymatob™ CEO , Sarah McDonald, bholding the NSW Medical Device Fund award  <left>, and talking with  the Hon. Brad Hazzard  at the evening of the announcement  <right> (source: Baymatob™)